Acotec Drug-Coated Balloon Catheter: Randomized, Multicenter, Controlled Clinical Study in Femoropopliteal Arteries: Evidence From the AcoArt I Trial

JACC: Cardiovascular Interventions

Volumn 9, Issue 18, 2016, Pages 1941-1949

  Jia, Xin ^a   Zhang, Jiwei ^b   Zhuang, Baixi ^c   Fu, Weiguo ^d   Wu, Danming ^e   Wang, Feng ^f   Zhao, Yu ^g   Guo, Pingfan ^h   Bi, Wei ⁱ   Wang, Shenming ^j   Guo, Wei ^a  

^a CHINESE PLA GENERAL HOSPITAL   (China)

^b SHANGHAI JIAO TONG UNIVERSITY SCHOOL OF MEDICINE   (China)

^c XIYUAN HOSPITAL   (China)

^d ZHONGSHAN HOSPITAL OF FUDAN UNIVERSITY   (China)

^e The People's Hospital of Liaoning Province   (China)

^f DALIAN MEDICAL UNIVERSITY   (China)

^g THE FIRST AFFILIATED HOSPITAL OF CHONGQING MEDICAL UNIVERSITY   (China)

^h FUJIAN MEDICAL UNIVERSITY   (China)

ⁱ HEBEI MEDICAL UNIVERSITY   (China)

^j SUN YAT SEN UNIVERSITY   (China)

more..

Author keywords

drug coated balloon catheter; femoropopliteal disease; randomized clinical trial; restenosis inhibition

Indexed keywords

ACETYLSALICYLIC ACID; CLOPIDOGREL; HEPARIN; PACLITAXEL; BIOCOMPATIBLE COATED MATERIAL; CARDIOVASCULAR AGENT;

ABSENCE OF COMPLICATIONS; ABSENCE OF SIDE EFFECTS; AGED; AMPUTATION; ANGIOGRAPHY; ANKLE BRACHIAL INDEX; ARTICLE; BALLOON CATHETER; CHINESE; CONTROLLED STUDY; CORE LABORATORY; DIABETES MELLITUS; DRUG COATING; DRUG EFFICACY; DRUG SAFETY; FEMALE; FEMORAL ARTERY; FOLLOW UP; HUMAN; IN-STENT RESTENOSIS; MAJOR CLINICAL STUDY; MALE; MULTICENTER STUDY; PERIPHERAL OCCLUSIVE ARTERY DISEASE; POPLITEAL ARTERY; PRIORITY JOURNAL; PROSPECTIVE STUDY; RANDOMIZED CONTROLLED TRIAL; REVASCULARIZATION; SELF EXPANDING STENT; SMOKING; ADVERSE EFFECTS; CHINA; CLINICAL TRIAL; DEVICES; DIAGNOSTIC IMAGING; EQUIPMENT DESIGN; LIMB SALVAGE; MIDDLE AGED; PATHOPHYSIOLOGY; PERCUTANEOUS TRANSLUMINAL ANGIOPLASTY; PERIPHERAL ARTERIAL DISEASE; RECURRENT DISEASE; TIME FACTOR; TREATMENT OUTCOME; VASCULAR ACCESS DEVICE; VASCULAR PATENCY;

AGED; AMPUTATION; ANGIOGRAPHY; ANGIOPLASTY, BALLOON; ANKLE BRACHIAL INDEX; CARDIOVASCULAR AGENTS; CHINA; COATED MATERIALS, BIOCOMPATIBLE; EQUIPMENT DESIGN; FEMALE; FEMORAL ARTERY; HUMANS; LIMB SALVAGE; MALE; MIDDLE AGED; PACLITAXEL; PERIPHERAL ARTERIAL DISEASE; POPLITEAL ARTERY; PROSPECTIVE STUDIES; RECURRENCE; TIME FACTORS; TREATMENT OUTCOME; VASCULAR ACCESS DEVICES; VASCULAR PATENCY;

EID: 84989191841     PISSN: 19368798     EISSN: 18767605     Source Type: Journal    
DOI: 10.1016/j.jcin.2016.06.055     Document Type: Article

References (19)

1. 1 Rogers, J.H., John, R., Laird, J.R., Overview of new technologies for lower extremity revascularization. Circulation 116 (2007), 2072–2085.
2. 2 Scheller, B., Speck, U., Abramjuk, C., Bernhardt, U., Böhm, M., Nickenig, G., Paclitaxel balloon coating—a novel method for prevention and therapy of restenosis. Circulation 110 (2004), 810–814.
3. 3 Freyhardt, P., Zeller, T., Kröncke, T.J., et al. Plasma levels following application of paclitaxel-coated balloon catheters in patients with stenotic or occluded femoropopliteal arteries. Fortschr Röntgenstr 183 (2011), 448–455.
4. 4 Werk, M., Albrecht, T., Meyer, R.-D., et al. Paclitaxel-coated balloons reduce restenosis after femoro-popliteal angioplasty. Evidence from the randomized PACIFIER trial. Circ Cardiovasc Interv 5 (2012), 831–840.
5. 5 Scheinert, D., Duda, S., Zeller, T., et al. The LEVANT I (Lutonix Paclitaxel-Coated Balloon for the Prevention of Femoropopliteal Restenosis) trial for femoropopliteal revascularization: first-in-human randomized trial of low dose drug-coated balloon versus uncoated balloon angioplasty. J Am Coll Cardiol Intv 7 (2014), 10–19.
6. 6 Scheinert, D., Schulte, K.-L., Zeller, T., Lammer, J., Tepe, G., Paclitaxel-releasing balloon in femoropopliteal lesions using a BTHC excipient: twelve-month results from the BIOLUX P-I randomized trial. J Endovasc Ther 22 (2015), 14–21.
7. 7 Liistro, F., Paclitaxel-eluting balloon vs. standard angioplasty to reduce recurrent restenosis in diabetic patients with in-stent restenosis of the superficial femoral and proximal popliteal arteries: the DEBATE-ISR study. J Endovasc Ther 21 (2014), 1–8.
8. 8 Laird, J.R., Schneider, P.D., Sustained durability of treatment effect using a drug-coated balloon for femoropopliteal lesions: 24-month results of IN.PACT SFA. J Am Coll Cardiol 66 (2015), 2329–2338.
9. 9 Scheinert, D., Treatment paradigms for the superficial femoral artery: are they a-changin’?. J Am Coll Cardiol Intv 3 (2012), 339–340.
10. 10 Fusaro, M., Cassese, S., Ndrepepa, G., et al. Paclitaxel-coated balloon or primary bare nitinol stent for revascularization of femoropopliteal artery: a meta-analysis of randomized trials versus uncoated balloon and an adjusted indirect comparison. Int J Cardiol 168 (2013), 4002–4009.
11. 11 Jaff, M.R., What's a doctor to do? Balloon, stents, drugs, drills, and treadmills: are we closer to the optimal algorithm?. J Am Coll Cardiol Intv 8 (2015), 1113–1114.
12. 12 Stabile, E., Virga, V., Salemme, L., et al. Drug-eluting balloon for treatment of superficial femoral artery in-stent restenosis. J Am Coll Cardiol Intv 60 (2012), 1739–1742.
13. 13 Fanelli, F., Cannavale, A., Boatta, E., et al. Lower limb multilevel treatment with drug-eluting balloons: 6-month results from the DEBELLUM randomized trial. J Endovasc Ther 19 (2012), 571–580.
14. 14 Katsanos, K., Karnabatidis, D., Kitrou, P., et al. Paclitaxel-coated balloon angioplasty vs. plain balloon dilation for the treatment of failing dialysis access: 6-month interim results from a prospective randomized controlled trial. J Endovasc Ther 19 (2012), 263–272.
15. 15 Liistro, F., Porto, I., Angioli, P., et al. Drug-Eluting Balloon in Peripheral Intervention for Below the Knee Angioplasty Evaluation (DEBATE-BTK): a randomized trial in diabetic patients with critical limb ischemia. Circulation 128 (2013), 615–621.
16. 16 Zeller, T., Baumgartner, I., Scheinert, D., et al. Drug-eluting balloon versus standard balloon angioplasty for infrapopliteal arterial revascularization in critical limb ischemia: 12-month results from the IN.PACT DEEP randomized trial. J Am Coll Cardiol 64 (2014), 1568–1576.
17. 17 Tepe, G., Laird, J., Schneider, P., et al. Drug-coated balloon versus standard percutaneous transluminal angioplasty for the treatment of superficial femoral and/or popliteal peripheral artery disease: 12-month results from the IN.PACT SFA randomized trial. Circulation 131 (2015), 495–502.
18. 18 Rosenfield, K., Jaff, M.J., White, C.J., et al. Trial of a paclitaxel-coated balloon for femoropopliteal artery disease. N Engl J Med 373 (2015), 145–153.
19. 19 Tepe, G., Zeller, T., Albrecht, T., et al. Local delivery of paclitaxel to inhibit restenosis during angioplasty of the leg. N Engl J Med 358 (2008), 689–699.